ANDA 78848, held by Zydus Lifesciences. Benazepril Hydrochloride.
As of Nov 16, 2026, ANDA 78848 (Benazepril Hydrochloride), held by Zydus Lifesciences, was first approved by FDA on May 23, 2008, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 23, 2008 | Original application | Approved | None posted |
| Benazepril Hydrochloride5MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride10MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride20MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride40MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Aug 7, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Oct 9, 2018 | Supplement 4Labeling · Standard review | Approved | None posted |
| Dec 21, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Aug 12, 2011 | Supplement 1Labeling | Approved | None posted |
| May 23, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters